R&D Credits After the OBBBA: What New England CPAs Should Revisit Now for 2026 Planning - Masscpas
Speakers
Date: Tuesday, May 27, 2026
Time: 12:00–1:00 PM ET
Location: Live virtual webinar
CPE Credit: 1.0 Tax CPE credit
Almost one year after the enactment of the One Big Beautiful Bill Act (OBBBA), CPAs across New England are reaching a critical reassessment point for R&D tax credit and Section 174 positions. With a full filing cycle now behind them, many innovation‑driven businesses adopted conservative or provisional approaches during early implementation—creating new planning considerations as firms look ahead to 2026.
In this CPE‑eligible session, EPSA USA will discuss why the one‑year post‑enactment mark is an important time for CPAs to revisit prior‑year R&D credits and Section 174 treatments before 2026 tax planning decisions are finalized. The session explores how post‑implementation experience, evolving legislative clarity, and upcoming compliance milestones—including time‑sensitive Section 174 amortization considerations—affect reassessment opportunities and client advisory discussions.
Designed for New England CPAs advising closely held and middle‑market businesses in manufacturing, technology, engineering, architecture, and life sciences, this program focuses on practical issue‑spotting rather than technical calculation. Attendees will gain a framework for identifying when prior positions may warrant review, coordinating with clients and specialists, and supporting informed planning conversations tied to cash‑flow, estimated taxes, and upcoming deadlines.
Share this article
